Soluna (SLNH) CEO Receives 416,394 Restricted Stock Award; 1.22M Shares Owned
Rhea-AI Filing Summary
Soluna Holdings, Inc. reporting person John Belizaire, who is listed as both Chief Executive Officer and a director, received a grant of 416,394 restricted shares of Common Stock on 09/01/2025. The award was approved by the Compensation Committee and vests in three annual tranches: 33% on 09/01/2026, 33% on 09/01/2027 and 34% on 09/01/2028, each contingent on continued service. Following the grant, the reporting person beneficially owns 1,221,700 shares. The Form 4 was signed by an attorney-in-fact on 09/02/2025.
Positive
- Alignment of interests: CEO award vests over three years, aligning management incentives with long-term shareholder value
- Committee approval: Award expressly approved by the Compensation Committee, indicating governance oversight
Negative
- Potential dilution: 416,394 restricted shares will increase outstanding shares upon vesting
- No performance conditions disclosed: Vesting is solely time-based, not tied to specific operational or financial targets
Insights
TL;DR: Standard service-based equity grant aligning CEO incentives with shareholder value over three years; non-immediate dilution.
The grant of 416,394 restricted shares appears to be a routine, committee-approved long-term incentive intended to retain and motivate the CEO. Vesting is time-based over three years with no performance conditions disclosed, which ties compensation to continued service rather than explicit performance milestones. Beneficial ownership post-grant is 1,221,700 shares, indicating meaningful insider exposure to the company’s equity value. Materiality for investors depends on company market capitalization, which is not provided here.
TL;DR: The award gives multi-year retention value to the CEO but lacks disclosed performance metrics.
The restricted stock award vests 33%/33%/34% annually, a common retention schedule that provides clear service-based incentives. Because the grant is in outright restricted shares (no strike price reported and price shown as $0), this is fully equity-settled and will dilute existing shareholders when shares vest. The Form does not disclose grant-date fair value or rationale, so assessing its relative size versus total outstanding shares or peer compensation is not possible from this filing alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 416,394 | $0.00 | $0.00 |
Footnotes (1)
- F1. Transaction reported is a grant of 416,394 restricted stock awards representing shares of Common Stock, par value $0.001 per share, of the issuer ("Common Stock"), which were approved by the Compensation Committee. The shares of Common Stock will vest 33% on September 1, 2026, 33% on September 1, 2027, and 34% on September 1, 2028, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
